The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that ...

The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic-;an effective antiviral that has since successfully treated millions.

Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) antiviral reduced the viral load in a phase 2 study in children, ...

Researchers from the University of Illinois have reported complementary discoveries that will improve scientists' ...

Scientists at the University of Helsinki, University of Eastern Finland and University of Turku are investigating the ...

Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...

4′-Fluorouridine works against RNA-dependent RNA polymerase, an enzyme that helps viruses assemble RNA. The compound has a ...

Press Release Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

NanoViricides: Pioneering the Future of Antiviral Therapies SHELTON, CT,024 – NanoViricides, Inc. (NYSE American: NNVC), a ...

Antiviral treatment for influenza is underutilized among children and adolescents, with a decline in use since the COVID-19 pandemic. During the 2023-2024 season, only 41%-48% of hospitalized and ...